Metraipolis › archive › dc_2fd9a790fe97

Advancing drug development for systemic sclerosis by prioritizing findings from human genetic association studies — Europe PMC PMID:41689177

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41689177
DOI
10.1093/rheumatology/keag084
License (as archived)
solo-consultazione
Archived
2026-11-05T11:43:02.760Z
SHA-256 of the archived text
f170219fb655c1d29ab5e6d1cb2f03d7722a92b45cff31572fce798404b74c70
Stable URL of this page
https://metraipolis.com/documento/dc_2fd9a790fe97

How to cite

Advancing drug development for systemic sclerosis by prioritizing findings from human genetic association studies — Europe PMC PMID:41689177 — Europe PMC (en), https://europepmc.org/article/MED/41689177 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fd9a790fe97 (Metraipolis archive dc_2fd9a790fe97, sha256 f170219fb655c1d29ab5e6d1cb2f03d7722a92b45cff31572fce798404b74c70)
BibTeX
@misc{dc2fd9a790fe97,
  title = {Advancing drug development for systemic sclerosis by prioritizing findings from human genetic association studies — Europe PMC PMID:41689177},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41689177},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fd9a790fe97; sha256 f170219fb655c1d29ab5e6d1cb2f03d7722a92b45cff31572fce798404b74c70},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41689177. Agents can read the archived copy with the MCP tool read_document.